Drawing for ACCU-POUR

USPTO serial 87795648

ACCU-POUR

Reviewed by CopyMark Law Group

Reg. 5565730Status 702Registered
Filing date
Status date
Registration date
Sep 18, 2018
Examiner
HSU, FONG
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with ACCU-POUR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher A. Proskey

Christopher A. Proskey BROWNWINICK LAW FIRM666 GRAND AVE # 2000DES MOINES, IA 50309United States

Goods and services

ClassDescriptionStatusFirst use
007Mobile concrete mixersACTIVEJun 7, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 4, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 4, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 4, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 6, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 6, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 18, 2024E815TEAS SECTION 8 & 15 RECEIVED
Mar 27, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 27, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 27, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 27, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 18, 2023REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 18, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 3, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 3, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 13, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 30, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 29, 2018DOCKASSIGNED TO EXAMINER
Feb 21, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 16, 2018NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance